Prelude Therapeutics Stock Performance
as on October 24, 2026 at 6:26 am IST
Day's Low
Day's High
$3.41$3.69
6.32%
Downside
1.37%
Upside
52 Week's Low
52 Week's High
$1.17$6.8367.77%
Downside
87.64%
Upside
Prelude Therapeutics share price movements today
- Previous Close
- $3.60
- Open
- $3.56
- Volume
- 419.8K
- Market Cap
- $291.3M
- Day's Low - High
- $3.41 - $3.69
- 52 Week Low - High
- $1.17 - $6.83
Prelude Therapeutics Historical Returns
- 1 Month Return
- -16.47 %
- 3 Month Return
- -8.4 %
- 1 Year Return
- + 140 %
- 3 Year Return
- + 68.22 %
- 5 Year Return
- -79.45 %
Prelude Therapeutics Stock Fundamentals & Key Indicators
Check Prelude Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$291.3M
EPS (TTM)
-0.79
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.62
Industry PE ratio
-7.12
PEG Ratio
-0.06
EBITDA
-58.9M
Revenue (TTM)
22.4M
Profit Margin
98.26%
Return On Equity TTM
-75.35%
Prelude Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Prelude Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $291.3M | -79.45% | -4.62 | 98.26% | 0.00% | |
| Neutral | $98.1B | -37.95% | -30.80 | -12.57% | 0.00% | |
| StrongBuy | $44.0B | NA | 27.47 | 87.82% | 0.00% | |
| StrongBuy | $132.9B | 191.61% | 30.28 | 86.04% | 0.00% | |
| Buy | $83.1B | 43.11% | 19.24 | 84.86% | 0.46% |
Stock Returns calculator for Prelude Therapeutics Stock including INR - Dollar returns
The Prelude Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Prelude Therapeutics investment value today
Current value as on today
₹2,62,463
Returns
₹1,62,463
(+162.46%)
Returns from Prelude Therapeutics Stock
₹1,42,667 (+142.67%)
Dollar Impact
₹19,797 (+19.8%)
Analyst Recommendation on Prelude Therapeutics Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Prelude Therapeutics. Average target price of $9.2
Prelude Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Prelude Therapeutics.
What analysts predicted
60.43%UPSIDE
Target Price
$9.2
Current Price
$3.64
Analyzed by
1 Analysts
High
$8
Target
$9.20
Low
$8
Prelude Therapeutics target price $9.2, a slight upside of 60.43% compared to current price of $3.64. According to 1 analysts rating.
Indian Investors' Interest in Prelude Therapeutics Stock
Search interest for Prelude Therapeutics Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Prelude Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Prelude Therapeutics Annual Profit & Loss
All numbers in Millions USD
Prelude Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Prelude Therapeutics Annual Cash Flow
All numbers in Millions USD
Prelude Therapeutics News & Key Events
Insights on Prelude Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, PRLD stock has moved up by 10.4%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 531.9%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 89.5%
About Prelude Therapeutics
| Organisation | Prelude Therapeutics |
| Headquarters | 175 Innovation Boulevard, Wilmington, DE, 19805, US |
| Industry | Biotechnology |
| CEO | Krishna Vaddi |
Key Management of Prelude Therapeutics
Name | Title |
|---|---|
Dr. Peggy A. Scherle Ph.D. | Chief Scientific Officer |
Ms. Aimee Crombie Ph.D. | Senior VP and Head of Strategic Planning & Operations |
Mr. Robert A. Doody Jr. | Senior Vice President of Investor Relations |
Ms. Michele Porreca M.B.A. | Chief People Officer |
Dr. Andrew P. Combs Ph.D. | Executive VP & Chief Chemistry Officer |
Mr. Naveen Babbar Ph.D. | Senior Vice President of Translation Medicine |
Dr. Krishna Vaddi D.V.M., Ph.D. | Founder, CEO & Director |
Mr. Bryant David Lim J.D. | CFO, Chief Legal Officer & Corporate Secretary |
Dr. Madhu Pudipeddi Ph.D. | Senior Vice President of Technical Operations |
Dr. Wan-Jen Hong M.D. | Senior Vice President of Clinical Development |
FAQs
What is Prelude Therapeutics share price today?
Prelude Therapeutics share price today is $3.64 as on . Prelude Therapeutics share today touched a day high of $3.69 and a low of $3.41.
What is the 52 week high and 52 week low for Prelude Therapeutics share?
Prelude Therapeutics share touched a 52 week high of $6.83 on and a 52 week low of $1.17 on . Prelude Therapeutics stock price today i.e. is trending at $3.64,which is 46.71% down from its 52 week high and 210.32% up from its 52 week low.
What is Prelude Therapeutics's market capitalisation today?
Prelude Therapeutics market capitalisation is $0.00T as on .
How to invest in Prelude Therapeutics Stock (PRLD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Prelude Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Prelude Therapeutics Stock (PRLD) from India?
Indian investors can start investing in Prelude Therapeutics (PRLD) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Prelude Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Prelude Therapeutics share’s latest price of $3.64 as on October 24, 2026 at 12:56 am IST, you will get 2.7473 shares of Prelude Therapeutics. Learn more about
fractional shares .
What are the returns that Prelude Therapeutics has given to Indian investors in the last 5 years?
Prelude Therapeutics stock has given -79.45% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?